RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceuticals

A collection of news and information related to Pharmaceuticals published by this site and its partners.

Top Pharmaceuticals Articles

Displaying items 23-33
  • Prices of new hepatitis C drugs are tough to swallow for insurers

    Prices of new hepatitis C drugs are tough to swallow for insurers
    A pair of new drugs to treat hepatitis C offer a cure for millions of Americans afflicted with the disease — but at a potentially staggering cost to taxpayers and health plans. Until now, therapies for hepatitis C helped only about half of...
  • FDA approves device to treat migraine headaches

    FDA approves device to treat migraine headaches
    The U.S. Food and Drug Administration has approved the marketing of an electronic medical device intended to treat migraine headaches. In an announcement released Tuesday, officials said the transcutaneous electrical nerve stimulation, or TENS, device...
  • Cultural production of ignorance provides rich field for study

    Cultural production of ignorance provides rich field for study
    Robert Proctor doesn't think ignorance is bliss. He thinks that what you don't know can hurt you. And that there's more ignorance around than there used to be, and that its purveyors have gotten much better at filling our heads with nonsense. Proctor, a...
  • A community makes a difference in providing effective healthcare

    A community makes a difference in providing effective healthcare
    Patients begin lining up outside Capitol City Family Health Center before the doors open at 7:30 a.m. The clinic, on a ragged stretch of the boulevard that separates the black and white sections of town, is a refuge for thousands of this old southern...
  • First trial of LSD as medicine in 40 years shows promise

    First trial of LSD as medicine in 40 years shows promise
    For the first time in more than four decades, the drug lysergic acid diethylamide -- better known as LSD -- has been the experimental adjunct to psychotherapy in a controlled clinical trial approved by the U.S. Food and Drug Administration. And a newly...
  • Suit filed to block new Arizona abortion regulations

    Suit filed to block new Arizona abortion regulations
    TUCSON -- Abortion providers have filed suit against Arizona to block a new rule that limits the use of medications to induce abortions. The rule is part of state-mandated abortion regulations that are scheduled to take effect April 1. On Wednesday,...
  • Drugmaker reverses course, offers treatment to stricken 7-year-old

    Drugmaker reverses course, offers treatment to stricken 7-year-old
    A 7-year-old Virginia boy struggling with a serious infection began a potentially lifesaving drug treatment Wednesday after his family's awareness campaign went viral and spurred the FDA and a pharmaceutical company to fast-track a new drug trial....
  • U.S. should reclassify prescription painkiller to cut rampant theft

    U.S. should reclassify prescription painkiller to cut rampant theft
    In his 30 years as a pharmacist, including three at a CVS Caremark store in Northern California, Wayne Wilson said it was all too common for drugstore employees to steal prescription drugs, which would often make their way to the black market. "It...
  • Letters: Drug abuse starts with the individual

    Re "Prescribers fuel drug epidemic," March 4 The Times offers a very simplistic analysis of America's drug dependence. As an emergency room physician, I see many chronic-pain patients who "run out" of their allotted opiates and then run to an...
  • HIV disappears in 'Los Angeles baby,' doctors say

    HIV disappears in 'Los Angeles baby,' doctors say
    A baby infected with HIV appears to be free of the virus after doctors at a Long Beach hospital initiated aggressive drug treatment just four hours after birth. A pediatrician at Miller Children's Hospital Long Beach and her colleagues disclosed the...
  • Gilead Sciences' $84,000 price for hepatitis drug is scrutinized

    Gilead Sciences' $84,000 price for hepatitis drug is scrutinized
    U.S. lawmakers have asked Gilead Sciences Inc. to justify the price of its new $84,000 drug for hepatitis C patients amid growing concern about the high cost to taxpayers and consumers. In a letter to the Foster City, Calif., company, Rep. Henry A....